Thonzonium Bromide
(Synonyms: 通佐溴胺) 目录号 : GC12127A monocationic surfactant with diverse biological activities
Cas No.:553-08-2
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Kinase experiment [1]: | |
ATP-dependent proton transport assay |
Purified vacuolar membrane vesicles (10 μg of protein) were incubated with alexidine dihydrochloride or thonzonium bromide at the indicated concentrations for 10 min on ice. ATP-dependent proton transport was measured as follows: Fluorescence quenching of ACMA was monitored (ex 410 nm, em 490 nm) upon the addition of 0.5mM ATP and 1mM MgSO4. Initial velocities were calculated for 15 s following addition of MgATP (n=2). The apparently enhanced rate measured with benzbromarone and tolazamide was not dose-dependent and was sustained in the controls, when the drugs were added to the reaction mixture prior to the membrane vesicles. |
Cell experiment [1]: | |
Cell lines |
In wild-type yeast cells |
Preparation method |
Limited solubility. General tips for obtaining a higher concentration: Please warm the tube at 37 ℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
Reaction Conditions |
Yeast cells expressing pHluorin were grown overnight to mid-log phase (0.4–0.6 A600/ml) and pre-incubated with 100 μM drug in 0.2% DMSO. |
Applications |
Treatment of yeast cells with thonzonium bromide significantly lowers the pH to (pHcyt 6.22±0.02), 10 μM thonzonium bromide reduces cell growth, with the cells developing a mild vma phenotype at 37 °C. Moreover, thonzonium bromide completely prevents yeast growth at 50 and 100 μM concentrations. |
References: 1. Chan CY, Prudom C, Raines SM, et al. Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p). J Biol Chem, 2012, 287(13): 10236-10250. |
Thonzonium Bromide is a surface active agent and an inhibitor of V-ATPase proton transport with EC50 value of 69 µM [1] [2].
Vacuolar ATPases (V-ATPases) are proton pumps that maintain pH homeostasis. V-ATPases couple the energy of ATP hydrolysis to proton transport across intracellular membranes [2].
Thonzonium Bromide is a surface active agent and an inhibitor of V-ATPase proton transport. In wild-type yeast cells, thonzonium bromide significantly decreased the cytosolic pH to 6.22. In vacuolar membrane vesicles, thonzonium bromide inhibited proton transport with EC50 value of 69 µM in a dose-dependent way. However, thonzonium bromide didn’t inhibit ATP hydrolysis, which suggested that thonzonium bromide uncoupled V-ATPase proton pumps. In wild-type yeast cells, thonzonium bromide (1 µM) didn’t inhibit cell growth. However, thonzonium bromide inhibited cell growth at 10 µM and caused a mild vma (vacuolar membrane ATPase) mutant growth phenotype. At concentrations up to 50 and 100 µM, thonzonium bromide completely inhibited yeast growth [2].
References:
[1]. Chafetz L, Greenough RC, Frank J. Thermal decomposition of thonzonium bromide. Pharm Res, 1986, 3(5): 298-301.
[2]. Chan CY, Prudom C, Raines SM, et al. Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p). J Biol Chem, 2012, 287(13): 10236-10250.
Cas No. | 553-08-2 | SDF | |
别名 | 通佐溴胺 | ||
化学名 | N-(2-((4-methoxybenzyl)(pyrimidin-2-yl)amino)ethyl)-N,N-dimethylhexadecan-1-aminium bromide | ||
Canonical SMILES | C[N+](CCN(C1=NC=CC=N1)CC(C=C2)=CC=C2OC)(C)CCCCCCCCCCCCCCCC.[Br-] | ||
分子式 | C32H55BrN4O | 分子量 | 591.71 |
溶解度 | ≥ 53.5 mg/mL in DMSO, ≥ 62.1 mg/mL in Water, ≥ 121.2 mg/mL in EtOH | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.69 mL | 8.4501 mL | 16.9002 mL |
5 mM | 0.338 mL | 1.69 mL | 3.38 mL |
10 mM | 0.169 mL | 0.845 mL | 1.69 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。